Elanco Animal Health vs Smith & Nephew
Elanco Animal Health (ELAN), health care, and Smith & Nephew (SNN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Elanco Animal Health and Smith & Nephew are valued at about the same: $12.9B and $12.8B. Over the past year Elanco Animal Health's share price has moved +23.5% and Smith & Nephew's -4.82%.
Key facts
- Elanco Animal Health market value
- $12.9B
- Smith & Nephew market value
- $12.8B
- Smith & Nephew P/E
- 21.0
- Elanco Animal Health revenue
- $4.7BFY to 2025-12-31
- Smith & Nephew revenue
- $6.2BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Elanco Animal Health | Smith & Nephew |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $12.9Bhigher | $12.8Blower |
| Revenue | $4.7Blower | $6.2Bhigher |
| Earnings | -$232Mlower | $625Mhigher |
| Employees | 9,400lower | 17,000higher |
| Total assets | $13.4Bhigher | $10.5Blower |
| Valuation | ||
| P/E | — | 21.0 |
| P/S | 2.7higher | 2.1lower |
| P/B | 1.9 | — |
| Dividend yield | 0.00% | — |
| Profitability | ||
| Operating margin | — | 12.9% |
| Balance sheet | ||
| Net assets | $6.5Bhigher | $5.3Blower |
| Total liabilities | $6.8Bhigher | $5.2Blower |
| Total debt | $4Bhigher | $3.1Blower |
| Cash on hand | $545Mlower | $557Mhigher |
| Price change | ||
| Today | -2.12%lower | -1.49%higher |
| 1 year | +23.5%higher | -4.82%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Charles Brandes (founder)0.5% / 0.4%
Elanco Animal Health only (4)
- Dodge & Cox team0.7%
- Primecap team0.6%
- Ken Griffin0.1%
- Lee Ainslie<0.1%
Smith & Nephew only (1)
- Sarah Ketterer0.5%
Percentages are each holding's share of that investor's reported portfolio (under "Both": Elanco Animal Health / Smith & Nephew). Who owns ELAN · Who owns SNN
More on Elanco Animal Health
Further comparisons
Elanco Animal Health against its closest peers
Smith & Nephew against its closest peers
Learn
Questions and answers
Which is bigger, Elanco Animal Health or Smith & Nephew?
By market value, Elanco Animal Health is the larger: $12.9B against $12.8B for Smith & Nephew. By revenue in its latest fiscal year, Smith & Nephew is the larger: $6.2B against $4.7B for Elanco Animal Health.
Which has more debt?
Elanco Animal Health: $4B, against $3.1B for Smith & Nephew. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Elanco Animal Health and Smith & Nephew?
In their latest 13F filings, Charles Brandes (founder) holds both.
Cite this page
Funkfolio, “Elanco Animal Health vs Smith & Nephew”, data as of 18 November 2026. https://funkfolio.com/compare/elan-vs-snn
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.